Qilu Pharmaceutical Co., Ltd.

Sourced facts

• Antibody-drug conjugate program QLS5132: ClinicalTrials.gov lead sponsor (1 trial) · clinicaltrials.gov/study/NCT06932094 · checked Oct 20, 2026
• China-based company (HQ: Jinan, China, per the HQ source above).